⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of DesiCorp Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
DesiCorp Inc.
↗Louisville, USA
DesiCorp Inc. is a biotechnology company focused on developing innovative solutions for the long-term preservation of blood components, specifically freeze-dried (lyophilized) red blood cells. Their technology aims to eliminate the need for refrigeration, enabling life-saving blood transfusions in austere environments such as battlefield settings, disaster relief zones, and remote rural clinics.
The company leverages expertise in life sciences, packaging solutions, and advanced materials to create infusion-ready products. By utilizing ultrasonic-mediated intracellular delivery of trehalose, they stabilize red blood cells for extended shelf-life, addressing critical logistics and supply chain challenges in trauma care.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Blood preservation / Cell therapy
SIZE & FINANCIALS
Employees:1-50
Revenue:$0.5M-$1M
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$6.03M
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Cell therapy, Biopreservation
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Safi Biotherapeutics (collaboration on freeze-drying of mRBCs)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Brett Janis - Co-Founder
Jonathan Kopechek - Co-Founder / Secretary
Michael Menze - Co-Founder
Scientific Founders:Brett Janis, Jonathan Kopechek, Michael Menze
LINKS
Website:desicorpinc.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with DesiCorp Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.